1. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg. 1999. 177:337–339.
2. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population based-study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer. 1997. 79:564–573.
7. Werner B, Abele J, Alveryd A, Bjorklund A, Franzen S, Granberg P, Landberg T, Lundell G, Lowhagen T, Sundblad R, et al. Multimodal therapy in anaplastic giant cell thyroid carcinoma. World J Surg. 1984. 8:64–70.
8. Nilsson O, Lindeberg J, Zedenius J, Ekman E, Tenvell J, Blomgren H, Grimelius L, Lundell G, Wallin G. Anaplastic giant cell carcinoma of the thyroid gland: Treatment and survival over a 25-year period. World J Surg. 1998. 22:725–730.
9. Giuffrida D, Lavenia G, Aiello RA, Di Blasi C, Gambera G, Pappalardo A, Petralia G, Ursino M, Failla G. Anaplastic carcinoma of the thyroid: diagnosis and treatment. Clin Ter. 2001. 152:255–261.
10. Yoshimura M, Kawamoto A, Nakasone K, Kakizaki D, Tsutsui H, Serizawa H, Abe K. Gallium-67 accumulation to the tumor thrombus in anaplastic thyroid cancer. Ann Nucl Med. 2003. 17:689–691.
11. Rodrigues RF, Roque L, Rosa-Santos J, Cid O, Soares J. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer. 2004. 90:492–496.
12. Wiseman SM, Loree TR, Rigual NR, Hicks WL Jr, Douglas WG, Anderson GR, Stoler DL. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck. 2003. 25:662–670.
13. Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL. Molecular evidence of anaplastic transformation in coexisting welldifferentiated and anaplastic carcinomas of the tyroid. Am J Surg Pathol. 2003. 27:1559–1564.
14. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery. 1991. 110:956–961.
15. Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol. 2003. 15:78–83.
16. Nel CJ, van Heerden JA, Goellner JR, Gharib H, McConahey WM, Taylor WF, Grant CS. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc. 1985. 60:51–58.
17. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer. 1990. 66:321–330.
18. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S. The Swedish Anaplastic Thyroid Cancer Group. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. Cancer. 1994. 74:1348–1354.
19. Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery. 2002. 131:245–248.
20. Besic N. The role of initial debulking surgery in the management of anaplastic thyroid carcinoma. Surgery. 2003. 133:453–454.
21. Melliere D, Berrahal D, Becquemin JP, Levy E, Lange F. Anaplastic cancers of thyroid. Is healing possible? Chirurgie. 1999. 124:52–57.
22. Heron DE, Karimpour S, Grigsby PW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol. 2002. 25:442–446.
23. Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M, Hjelm Skog AL, Wallin G. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer. 2002. 86:1848–1853.
24. Mitchell G, Huddart R, Harmer C. Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol. 1999. 50:33–38.
25. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol. 2002. 9:57–64.